Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Dolladille, Charles"" wg kryterium: Autor


Tytuł:
Neurocognitive impairment in females with breast cancer treated with endocrine therapy and CDK4/6 inhibitors: a pharmacovigilance study using the World Health Organization's database.
Autorzy:
Prevost, Rachel
Chretien, Basile
Minoc, Elise-Marie
Dolladille, Charles
Da-Silva, Angélique
Nehme, Ahmad
Joly, Florence
Lelong-Boulouard, Véronique
Bastien, Etienne
Pokaż więcej
Temat:
CYCLIN-dependent kinase inhibitors
HORMONE therapy
BREAST cancer
DATABASES
WORLD health
Źródło:
Frontiers in Pharmacology; 2023, p1-8, 8p
Przedsiębiorstwo/ jednostka:
WORLD Health Organization
Czasopismo naukowe
Tytuł:
Drug-associated acquired hemophilia A: an analysis based on 185 cases from the WHO pharmacovigilance database.
Autorzy:
Konstantinov K; Haematology Laboratory, CHU Caen Normandie, Caen, France.
Dolladille C; UNICAEN, EA4650 SEILIRM, CHU de Caen Normandie, Normandie University, Caen, France.; Department of Pharmacology, CHU de Caen Normandie, Caen, France.
Gillet B; Haematology Laboratory, CHU Caen Normandie, Caen, France.
Alexandre J; UNICAEN, EA4650 SEILIRM, CHU de Caen Normandie, Normandie University, Caen, France.; Department of Pharmacology, CHU de Caen Normandie, Caen, France.
Aouba A; Department of Internal Medicine, UNICAEN, CHU de Caen Normandie, Normandie University, Caen, France.
Deshayes S; Department of Internal Medicine, UNICAEN, CHU de Caen Normandie, Normandie University, Caen, France.
Repesse Y; Haematology Laboratory, CHU Caen Normandie, Caen, France.; Unicaen, Inserm, Physiopathology and Imaging of Neurological Disorders (PhIND), Normandie University, Caen, France.
Pokaż więcej
Źródło:
Haemophilia : the official journal of the World Federation of Hemophilia [Haemophilia] 2023 Jan; Vol. 29 (1), pp. 186-192. Date of Electronic Publication: 2022 Nov 11.
Typ publikacji:
Journal Article
MeSH Terms:
Hemophilia A*/drug therapy
Hemophilia A*/epidemiology
Drug-Related Side Effects and Adverse Reactions*/epidemiology
Drug-Related Side Effects and Adverse Reactions*/etiology
Autoimmune Diseases*
Male ; Humans ; Female ; Child ; Adolescent ; Young Adult ; Adult ; Middle Aged ; Aged ; Aged, 80 and over ; Pharmacovigilance ; Bayes Theorem ; World Health Organization
SCR Disease Name:
Factor 8 deficiency, acquired
Czasopismo naukowe
Tytuł:
Association between road traffic accidents and drugs belonging to the antiseizure medications class: A pharmacovigilance analysis in VigiBase.
Autorzy:
Chrétien, Basile
Nguyen, Sophie
Dolladille, Charles
Morice, Pierre‐Marie
Heraudeau, Marie
Loilier, Magalie
Fedrizzi, Sophie
Bourgine, Joanna
Cesbron, Alexandre
Alexandre, Joachim
Bocca, Marie‐Laure
Freret, Thomas
Lelong‐Boulouard, Véronique
Pokaż więcej
Temat:
DRUG traffic
DRUG interactions
TRAFFIC accidents
DRUG monitoring
DRUGS
DISEASE risk factors
NALTREXONE
Źródło:
British Journal of Clinical Pharmacology; Jan2023, Vol. 89 Issue 1, p222-231, 10p
Przedsiębiorstwo/ jednostka:
WORLD Health Organization
Czasopismo naukowe
Tytuł:
Left atrial strain quantified after myocardial infarction is associated with early left ventricular remodeling.
Autorzy:
Legallois D; Department of Cardiology, Normandie Univ, UNICAEN, CHU de Caen Normandie, Caen, France.; Signalisation, électrophysiologie et imagerie des lésions d'ischémie-reperfusion myocardique, FHU REMOD-VHF, Caen, France.
Hodzic A; Department of Clinical Physiology, Normandie Univ, UNICAEN, CHU de Caen Normandie, INSERM Comete, Caen, France.
Milliez P; Department of Cardiology, Normandie Univ, UNICAEN, CHU de Caen Normandie, Caen, France.; Signalisation, électrophysiologie et imagerie des lésions d'ischémie-reperfusion myocardique, FHU REMOD-VHF, Caen, France.
Manrique A; Signalisation, électrophysiologie et imagerie des lésions d'ischémie-reperfusion myocardique, FHU REMOD-VHF, Caen, France.; Department of Nuclear Medicine, Normandie Univ, UNICAEN, CHU de Caen Normandie, Caen, France.
Dolladille C; Signalisation, électrophysiologie et imagerie des lésions d'ischémie-reperfusion myocardique, FHU REMOD-VHF, Caen, France.; Department of Pharmacology, Normandie Univ, UNICAEN, CHU de Caen Normandie, PICARO Cardio-Oncology program, Caen, France.
Saloux E; Department of Cardiology, Normandie Univ, UNICAEN, CHU de Caen Normandie, Caen, France.; Signalisation, électrophysiologie et imagerie des lésions d'ischémie-reperfusion myocardique, FHU REMOD-VHF, Caen, France.
Beygui F; Department of Cardiology, Normandie Univ, UNICAEN, CHU de Caen Normandie, Caen, France.; Signalisation, électrophysiologie et imagerie des lésions d'ischémie-reperfusion myocardique, FHU REMOD-VHF, Caen, France.; ACTION academic research group, Pitié-Salpêtrière University Hospital, Paris, France.
Pokaż więcej
Źródło:
Echocardiography (Mount Kisco, N.Y.) [Echocardiography] 2022 Dec; Vol. 39 (12), pp. 1581-1588. Date of Electronic Publication: 2022 Nov 14.
Typ publikacji:
Journal Article; Comment
MeSH Terms:
Atrial Fibrillation*
Myocardial Infarction*/complications
Myocardial Infarction*/diagnostic imaging
Humans ; Male ; Middle Aged ; Aged ; Ventricular Remodeling ; Reproducibility of Results
Czasopismo naukowe
Tytuł:
Systematic analysis of drug-associated myocarditis reported in the World Health Organization pharmacovigilance database
Autorzy:
Nguyen, Lee S.Aff1, Aff2, IDs41467021276318_cor1
Cooper, Leslie T.
Kerneis, Mathieu
Funck-Brentano, Christian
Silvain, Johanne
Brechot, Nicolas
Hekimian, Guillaume
Ammirati, Enrico
Ben M’Barek, Badr
Redheuil, Alban
Gandjbakhch, Estelle
Bihan, Kevin
Lebrun-Vignes, BénédicteAff2, Aff8
Ederhy, Stephane
Dolladille, Charles
Moslehi, Javid J.
Salem, Joe-ElieAff2, Aff11, IDs41467021276318_cor17
Pokaż więcej
Źródło:
Nature Communications. 13(1)
Czasopismo naukowe
Tytuł:
COVID-19 vaccines associated with vasovagal malaise: A retrospective study in two mass vaccination centers and analysis of the WHO pharmacovigilance database
Autorzy:
Chrétien, Basile
Stroiazzo, Rhéda
Troussier, Leila
Le Houssel, Pierre-Yves
Jacquet, Magali
Lheureux, Cécile
Voyen, Sandy
Court, Philippe
Dolladille, Charles
Alexandre, Joachim
Fedrizzi, Sophie
Humbert, Xavier
Pokaż więcej
Źródło:
Human Vaccines & Immunotherapeutics; November 2022, Vol. 18 Issue: 6
Periodyk
Tytuł:
[Lu]Lu-DOTATATE peptide receptor radionuclide therapy–associated myeloid neoplasms: insights from the WHO pharmacovigilance database.
Autorzy:
Vigne, Jonathan (AUTHOR)
Chrétien, Basile (AUTHOR)
Bignon, Anne-Laure (AUTHOR)
Bouhier-Leporrier, Karine (AUTHOR)
Dolladille, Charles (AUTHOR)
Pokaż więcej
Źródło:
European Journal of Nuclear Medicine & Molecular Imaging. Aug2022, Vol. 49 Issue 10, p3332-3333. 2p. 1 Chart.
Czasopismo naukowe
Tytuł:
[ Lu]Lu-DOTATATE peptide receptor radionuclide therapy-associated myeloid neoplasms: insights from the WHO pharmacovigilance database.
Autorzy:
Vigne J; Department of Nuclear Medicine, CHU de Caen Normandie, Normandie Université, UNICAEN, Avenue de La Côte de Nacre, CS 30001, 14033 Caen CEDEX 9, Caen, France. .; Department of Pharmacy, CHU de Caen Normandie, Normandie Université, UNICAEN, 14000, Caen, France. .; INSERM U1237, PhIND, Institut Blood and Brain @ Caen-Normandie, Centre Cyceron, Normandie Université, UNICAEN, 14000, Caen, France. .
Chrétien B; Pharmacoepidemiology Unit, Department of Pharmacology, Pharmacovigilance Regional Center, Caen University Hospital, Caen, France.
Bignon AL; Department of Hepato-Gastroenterology and Nutrition, Caen University Hospital, 14000, Caen, France.
Bouhier-Leporrier K; Department of Hepato-Gastroenterology and Nutrition, Caen University Hospital, 14000, Caen, France.
Dolladille C; Department of Pharmacology, Caen University Hospital, INSERM U1086 ANTICIPE, Normandie University, UNICAEN, Caen, France.
Pokaż więcej
Źródło:
European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2022 Aug; Vol. 49 (10), pp. 3332-3333. Date of Electronic Publication: 2022 May 06.
Typ publikacji:
Letter
MeSH Terms:
Neoplasms*
Neuroendocrine Tumors*/radiotherapy
Organometallic Compounds*/adverse effects
Humans ; Octreotide/adverse effects ; Pharmacovigilance ; Positron-Emission Tomography ; Radioisotopes ; Radionuclide Imaging ; Radiopharmaceuticals ; Receptors, Peptide ; World Health Organization
Opinia redakcyjna

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies